Ivan Menacho-Plaza
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The oncogenic CCDC6-RET fusion protein is a dual ATP- and ADP-dependent kinase.
Journal: Nature communications
Published: July 03, 2024
PM534, an Optimized Target-Protein Interaction Strategy through the Colchicine Site of Tubulin.
Journal: Journal of medicinal chemistry
Published: January 31, 2024
An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function.
Journal: Nature communications
Published: September 27, 2022
Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability.
Journal: Journal of advanced research
Published: August 23, 2021
Structure and function of RET in multiple endocrine neoplasia type 2.
Journal: Endocrine-related cancer
Published: November 21, 2017
Mechanisms of RET signaling in cancer: current and future implications for targeted therapy.
Journal: Cellular signalling
Published: March 08, 2014
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase.
Journal: Molecular and cellular endocrinology
Published: March 25, 2013
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.
Journal: The Journal of biological chemistry
Published: April 02, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026